NR1H2 and breast cancer: Taken together with our findings concerning the LXRα/β expression in T47D, MCF-7, and MDA-MB-231 cells, we concluded that LXRβ is the overwhelmingly dominant subtype of LXRs in breast cancer at the protein levels.